Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0010628
|
positive regulation of gene expression |
PPARA,CSF1,MAFB,ATXN1,SMAD5,ACVR1,KLF4,SMAD4,ZFPM2,ESR1,PPARG,APP, |
3.58E-9 |
GO:0010604
|
positive regulation of macromolecule metabolic process |
BMPR2,CSF1,MAFB,ACVR1,ATXN1,ESR1,PPARG,APP,PPARA,SMAD5,SMAD4,KLF4,ZFPM2, |
1.63E-8 |
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter |
PPARA,MAFB,ATXN1,SMAD5,KLF4,SMAD4,ZFPM2,PPARG,APP, |
3.00E-7 |
GO:0007389
|
pattern specification process |
BMPR2,HOXA5,HOXA10,MAFB,SMAD5,ACVR1,SMAD4,MEOX2, |
5.14E-7 |
GO:0045941
|
positive regulation of transcription |
PPARA,MAFB,ATXN1,SMAD5,ACVR1,KLF4,SMAD4,ZFPM2,PPARG,APP, |
5.90E-7 |
|
GO:0048598
|
embryonic morphogenesis |
BMPR2,HOXA5,HOXA10,MAFB,DICER1,ACVR1,KLF4,SMAD4, |
1.31E-6 |
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
PPARA,MAFB,ATXN1,SMAD5,ACVR1,KLF4,SMAD4,ZFPM2,PPARG,APP, |
1.37E-6 |
GO:0051173
|
positive regulation of nitrogen compound metabolic process |
PPARA,MAFB,ATXN1,SMAD5,ACVR1,KLF4,SMAD4,ZFPM2,PPARG,APP, |
1.78E-6 |
GO:0045893
|
positive regulation of transcription, DNA-dependent |
PPARA,MAFB,ATXN1,SMAD5,KLF4,SMAD4,ZFPM2,PPARG,APP, |
2.00E-6 |
GO:0010557
|
positive regulation of macromolecule biosynthetic process |
PPARA,MAFB,ATXN1,SMAD5,ACVR1,KLF4,SMAD4,ZFPM2,PPARG,APP, |
2.03E-6 |
GO:0051254
|
positive regulation of RNA metabolic process |
PPARA,MAFB,ATXN1,SMAD5,KLF4,SMAD4,ZFPM2,PPARG,APP, |
2.13E-6 |
GO:0031328
|
positive regulation of cellular biosynthetic process |
PPARA,MAFB,ATXN1,SMAD5,ACVR1,KLF4,SMAD4,ZFPM2,PPARG,APP, |
2.98E-6 |
GO:0009891
|
positive regulation of biosynthetic process |
PPARA,MAFB,ATXN1,SMAD5,ACVR1,KLF4,SMAD4,ZFPM2,PPARG,APP, |
3.35E-6 |
GO:0006355
|
regulation of transcription, DNA-dependent |
HOXA5,MAFB,HOXA10,RUNX3,ATXN1,ESR1,PPARG,APP,PPARA,SMAD5,SMAD4,KLF4,MEOX2,ZFPM2, |
6.35E-6 |
GO:0051252
|
regulation of RNA metabolic process |
HOXA5,MAFB,HOXA10,RUNX3,ATXN1,ESR1,PPARG,APP,PPARA,SMAD5,SMAD4,KLF4,MEOX2,ZFPM2, |
8.16E-6 |
GO:0045449
|
regulation of transcription |
HOXA5,MAFB,HOXA10,RUNX3,ACVR1,ATXN1,DNM2,ESR1,PPARG,APP,PPARA,SMAD5,KLF4,SMAD4,MEOX2,ZFPM2, |
1.55E-5 |
GO:0048729
|
tissue morphogenesis |
BMPR2,HOXA5,RUNX3,ACVR1,KLF4,SMAD4, |
2.06E-5 |
GO:0003013
|
circulatory system process |
PPARA,BMPR2,TAC1,SMAD5,MEOX2,PPARG, |
2.42E-5 |
GO:0008015
|
blood circulation |
PPARA,BMPR2,TAC1,SMAD5,MEOX2,PPARG, |
2.42E-5 |
GO:0003002
|
regionalization |
BMPR2,HOXA5,HOXA10,MAFB,SMAD4,MEOX2, |
3.19E-5 |
GO:0006357
|
regulation of transcription from RNA polymerase II promoter |
PPARA,MAFB,ATXN1,SMAD5,KLF4,SMAD4,ZFPM2,PPARG,APP, |
4.40E-5 |
GO:0035295
|
tube development |
BMPR2,HOXA5,DICER1,ACVR1,SMAD4,ZFPM2, |
5.41E-5 |
GO:0045597
|
positive regulation of cell differentiation |
BMPR2,CSF1,SMAD5,ACVR1,SMAD4,PPARG, |
6.54E-5 |
GO:0030509
|
BMP signaling pathway |
BMPR2,SMAD5,ACVR1,SMAD4, |
7.92E-5 |
GO:0009952
|
anterior/posterior pattern formation |
BMPR2,HOXA5,HOXA10,SMAD4,MEOX2, |
1.37E-4 |
GO:0051094
|
positive regulation of developmental process |
BMPR2,CSF1,SMAD5,ACVR1,SMAD4,PPARG, |
1.63E-4 |
GO:0048754
|
branching morphogenesis of a tube |
HOXA5,DICER1,ACVR1,SMAD4, |
2.54E-4 |
GO:0010629
|
negative regulation of gene expression |
PPARA,DICER1,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
3.16E-4 |
GO:0007369
|
gastrulation |
BMPR2,ACVR1,KLF4,SMAD4, |
3.16E-4 |
GO:0001763
|
morphogenesis of a branching structure |
HOXA5,DICER1,ACVR1,SMAD4, |
3.73E-4 |
GO:0030278
|
regulation of ossification |
BMPR2,CSF1,SMAD5,ACVR1, |
4.35E-4 |
GO:0031667
|
response to nutrient levels |
PPARA,BMPR2,ATG16L1,KLF4,PPARG, |
5.07E-4 |
GO:0042127
|
regulation of cell proliferation |
BMPR2,CSF1,IFITM1,TAC1,RUNX3,KLF4,SMAD4,PPARG, |
5.44E-4 |
GO:0045596
|
negative regulation of cell differentiation |
PPARA,MAFB,DICER1,KLF4,PPARG, |
7.17E-4 |
GO:0009991
|
response to extracellular stimulus |
PPARA,BMPR2,ATG16L1,KLF4,PPARG, |
7.68E-4 |
GO:0030324
|
lung development |
BMPR2,HOXA5,DICER1,ZFPM2, |
8.74E-4 |
GO:0008217
|
regulation of blood pressure |
PPARA,BMPR2,TAC1,PPARG, |
9.00E-4 |
GO:0030323
|
respiratory tube development |
BMPR2,HOXA5,DICER1,ZFPM2, |
9.53E-4 |
GO:0007178
|
transmembrane receptor protein serine/threonine kinase signaling pathway |
BMPR2,SMAD5,ACVR1,SMAD4, |
9.81E-4 |
GO:0006350
|
transcription |
PPARA,BMPR2,HOXA5,HOXA10,MAFB,RUNX3,SMAD5,KLF4,SMAD4,ZFPM2,ESR1,PPARG, |
9.88E-4 |
GO:0010743
|
regulation of foam cell differentiation |
PPARA,CSF1,PPARG, |
1.03E-2 |
GO:0045669
|
positive regulation of osteoblast differentiation |
BMPR2,SMAD5,ACVR1, |
1.03E-2 |
GO:0060541
|
respiratory system development |
BMPR2,HOXA5,DICER1,ZFPM2, |
1.12E-2 |
GO:0016481
|
negative regulation of transcription |
PPARA,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
1.60E-2 |
GO:0042325
|
regulation of phosphorylation |
BMPR2,CSF1,ATXN1,SMAD4,MET,APP, |
1.71E-2 |
GO:0035239
|
tube morphogenesis |
HOXA5,DICER1,ACVR1,SMAD4, |
1.79E-2 |
GO:0051174
|
regulation of phosphorus metabolic process |
BMPR2,CSF1,ATXN1,SMAD4,MET,APP, |
2.04E-2 |
GO:0019220
|
regulation of phosphate metabolic process |
BMPR2,CSF1,ATXN1,SMAD4,MET,APP, |
2.04E-2 |
GO:0001707
|
mesoderm formation |
BMPR2,ACVR1,KLF4, |
2.14E-2 |
GO:0010605
|
negative regulation of macromolecule metabolic process |
PPARA,DICER1,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
2.26E-2 |
GO:0045165
|
cell fate commitment |
SMAD5,KLF4,SMAD4,PPARG, |
2.32E-2 |
GO:0048332
|
mesoderm morphogenesis |
BMPR2,ACVR1,KLF4, |
2.39E-2 |
GO:0042592
|
homeostatic process |
LDLR,CSF1,TAC1,ATXN1,SMAD5,PPARG,APP, |
2.53E-2 |
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
PPARA,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
2.58E-2 |
GO:0001704
|
formation of primary germ layer |
BMPR2,ACVR1,KLF4, |
2.64E-2 |
GO:0051172
|
negative regulation of nitrogen compound metabolic process |
PPARA,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
2.74E-2 |
GO:0045667
|
regulation of osteoblast differentiation |
BMPR2,SMAD5,ACVR1, |
3.05E-2 |
GO:0010558
|
negative regulation of macromolecule biosynthetic process |
PPARA,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
3.44E-2 |
GO:0031327
|
negative regulation of cellular biosynthetic process |
PPARA,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
3.84E-2 |
GO:0007167
|
enzyme linked receptor protein signaling pathway |
BMPR2,SMAD5,ACVR1,SMAD4,MET, |
3.86E-2 |
GO:0009890
|
negative regulation of biosynthetic process |
PPARA,ATXN1,KLF4,SMAD4,ZFPM2,PPARG, |
4.20E-2 |
GO:0045892
|
negative regulation of transcription, DNA-dependent |
PPARA,KLF4,SMAD4,ZFPM2,PPARG, |
4.45E-2 |
GO:0008285
|
negative regulation of cell proliferation |
IFITM1,RUNX3,KLF4,SMAD4,PPARG, |
4.68E-2 |
GO:0051253
|
negative regulation of RNA metabolic process |
PPARA,KLF4,SMAD4,ZFPM2,PPARG, |
4.73E-2 |
GO:0009725
|
response to hormone stimulus |
PPARA,LDLR,TAC1,ESR1,PPARG, |
4.96E-2 |
GO:0007612
|
learning |
TAC1,ATXN1,APP, |
5.87E-2 |
GO:0007179
|
transforming growth factor beta receptor signaling pathway |
SMAD5,ACVR1,SMAD4, |
5.87E-2 |
GO:0009719
|
response to endogenous stimulus |
PPARA,LDLR,TAC1,ESR1,PPARG, |
7.01E-2 |
GO:0048514
|
blood vessel morphogenesis |
DICER1,ACVR1,MEOX2,ZFPM2, |
7.46E-2 |
GO:0007517
|
muscle organ development |
MEOX2,ZFPM2,MET,APP, |
7.46E-2 |
GO:0010891
|
negative regulation of sequestering of triglyceride |
PPARA,PPARG, |
7.66E-2 |
GO:0010324
|
membrane invagination |
LDLR,RAB5A,DNM2,APP, |
8.37E-2 |
GO:0006897
|
endocytosis |
LDLR,RAB5A,DNM2,APP, |
8.37E-2 |
GO:0007498
|
mesoderm development |
BMPR2,ACVR1,KLF4, |
8.81E-2 |
GO:0048469
|
cell maturation |
RUNX3,PPARG,APP, |
9.04E-2 |
GO:0010871
|
negative regulation of receptor biosynthetic process |
PPARA,PPARG, |
9.57E-2 |
|
|
|
|
|
|